3xper Innoventure Limited’s Post

The pandemic tested the resilience of the global pharmaceutical industry, and #India emerged stronger than ever. From 2020 to 2024, India’s pharmaceutical market has witnessed exponential growth, bolstered by its status as the “pharmacy of the world.” Many #pharma companies are still managing to sustain or grow the market capitalisation while some companies are facing roller coaster rides. As the market continues to grow, valued at over $50 billion in 2024, the Indian pharmaceutical industry is poised to play an even larger role in shaping the future of healthcare globally. Below image shows top Indian pharma companies by market capitalisation with yoy growth in 2024. #marketdata #healthcare #business #bse

𝐇𝐨𝐰 𝐌𝐮𝐫𝐥𝐢 𝐊𝐫𝐢𝐬𝐡𝐧𝐚 𝐏𝐡𝐚𝐫𝐦𝐚 𝐢𝐬 𝐑𝐞𝐝𝐞𝐟𝐢𝐧𝐢𝐧𝐠 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐒𝐭𝐚𝐧𝐝𝐚𝐫𝐝𝐬 𝐢𝐧 𝐈𝐧𝐝𝐢𝐚 With a client base of over 200, including more than 64 leading international companies, and a turnover exceeding US$ 6 million, Murli Krishna Pharma Pvt. Ltd. is making significant impact in the pharmaceutical industry in India, while setting new benchmarks and redefining standards. Murli Krishna Pharma’s performance speaks of its capabilities, with a cumulative growth of over 60% in the last three years.  As a young and dynamic drug delivery systems (DDS) company in India, MKPPL provides a range of effective solutions to optimize the delivery of pharmaceutical preparations. Established in 2004 by Dr. Satya Vadlamani and Dr. Vijay K. Shastri, the company is driven by the vision to provide the best possible range of international quality products at competitive prices through integration, research, innovation, technology, and development. Read More: https://lnkd.in/ghch_cFw #Murlikrishnapharma #PharmaInnovation #HealthcareRevolution #IndianPharma #QualityHealthcare #PharmaExcellence #RedefiningPharma #MurliKrishnaPharma #PharmaceuticalStandards #PharmaLeadership #InnovativeMedicine #HealthcareStandards #PharmaPioneers #FutureOfPharma #HealthTech #PharmaSuccess

#SectoralUpdate With a robust pharmaceutical industry and a strong emphasis on affordability and accessibility, India serves as a key supplier of essential medications worldwide. India holds a pivotal position in global healthcare by virtue of its extensive capabilities in manufacturing generic medicines. Moreover, Nifty Pharma Index saw an all time high breakout in November, 2023 which grabbed our attention. Here's overview of Indian Pharma sector and reasons for breakout highlighted. You can read in detail about it on our website: https://lnkd.in/dJ6Yfi_i #Wealthculture #Pharma #Healthcare #GenericMedicines #NiftyPharma #Investment #MarketTrends #WealthCulture #IndiaPharma #SectorUpdate #StockMarket #PharmaceuticalIndustry

How can your pharma manufacturing facility mitigate the risk of managing multiple vendors? Recent trends indicate that utilizing a single source provider that offers end-to-end solutions, like Almac Pharma Services can streamline communication and collaboration, amongst other benefits. “Scientific excellence and continuity through the drug development process cannot be understated and reduces many uncertainties inherent in a multi-supplier, multi-site process, resulting in improved coordination and efficiency with reduced time to clinic and ultimately to the market.” Read more about the benefits of a single-source CDMO at https://hubs.ly/Q02KcDcc0 – #USPharma24 #GenerisPMOS #CDMO #riskmitigation #pharma #vendormanagement

Exciting developments in the pharmaceutical industry! 🚀 Major MNC pharma companies are reshaping their approach in India by forging strategic partnerships with homegrown pharma firms boasting robust infrastructure and resources. This collaborative leap promises to extend healthcare access to every corner of the nation, fostering mutual growth and innovation. 💊💡 #PharmaAlliance #HealthcareAccess #CollaborationWins #MNCIndiaPartnership #InnovationExchange #PharmaGrowth #IndianPharmaStrength #HealthcareRevolution #GlobalLocalPartnership #MedTechSynergy

Our latest report- 'Contract Research and Manufacturing Service in India' is now LIVE on our website! Here’s a sneak peek at some of the key insights! ➡️ Compiled through our flagship product, 1nsights, this comprehensive pharmaceutical sector study delves deep into the Indian CRAMS industry, offering an in-depth analysis of its current state and future prospects. With India emerging as a leading destination for outsourced pharmaceutical services offering a wide range of capabilities across the drug development and manufacturing value chain, CRAMS services have embraced innovation across all facets of its operations, from research and development to manufacturing, quality assurance, and regulatory compliance. Indian CRAMS companies are focusing on enhancing their capabilities, investing in innovation, and strengthening their global presence to maintain a competitive edge in the evolving pharmaceutical landscape. Gain comprehensive insights and developments from the full report on our website! ⬇️Download here: https://lnkd.in/gqWH-HEx Stay tuned with 1Lattice for more industry trends from the study! #EnablingBetterDecisions #1nsights #Pharmaceuticals #CRAMS #Innovation #India Amar Choudhary Hitesh Gossain Sanjay Sachdeva Praneet Singhal Ashish Dhir Abhilasha Jaju Abhishek Maiti

Elevate Your Vision: Pharma Solutions by Zenvision Pharma At Zenvision Pharma LLP, we're driven by a singular vision: to revolutionize pharmaceuticals by providing innovative, patient-centric solutions. We're a leading pharmaceutical company in Navi Mumbai, India, dedicated to developing, manufacturing, and marketing a wide range of high-quality, affordable medications across various pharma segments. Here's a glimpse into what sets us apart: ✅ Extensive product portfolio: We offer a diverse range of medicines, including prescription drugs, over-the-counter medications, and nutraceuticals, catering to various healthcare needs. ✅Unwavering commitment to quality: We adhere to the strictest quality standards throughout the manufacturing process, ensuring the safety and efficacy of our products. ✅Focus on affordability: We believe that everyone deserves access to quality healthcare, which is why we strive to make our medications accessible to a wider population. ✅Cutting-edge research and development: We invest heavily in R&D to bring forth new and innovative treatments that address unmet medical needs. ✅Dedicated team of experts: Our team comprises passionate and experienced professionals who are committed to delivering exceptional service to our customers. We offer a variety of services, including: ✅Contract Manufacturing ✅Product Development ✅Clinical Research ✅Regulatory Support ✅Innovative Research Connect with us today to learn more about our services and how we can help you achieve your pharma business goals. #pharmaceuticals #india #innovation #quality #affordability #rnd #patientcentricity

India's pharmaceutical sector continues to make waves on the global stage, securing a remarkable 16.9% share of the market for penicillin and streptomycin-based medicaments. This achievement underscores India's commitment to quality, innovation, and excellence in healthcare. Join us in celebrating this significant milestone and exploring new opportunities for growth and collaboration in the global pharmaceutical industry! Connect with Industry Experts and we can help you navigate the opportunities. https://lnkd.in/dr9BMYVv #industryexperts #business #growth #industryexpertspvtltd #indianmanufacturing #foreigntrade #PharmaTriumph #GlobalHealthLeaders #BreakingRecord #MedicationInnovation #IndianPharma #GlobalExports #MedicineTrade #HealthcareIndustry #Pharmaceuticals #IndiaExports #TradeLeadership #EconomicGrowth #PharmaExcellence #GlobalTrade #India #HealthcareInnovation #ExportSuccess #MadeInIndia #PharmaLeaders #TradeAchievements #GlobalMarket #InnovationInHealthcare

Exciting developments in the pharmaceutical industry! 🚀 Major MNC pharma companies are reshaping their approach in India by forging strategic partnerships with homegrown pharma firms boasting robust infrastructure and resources. This collaborative leap promises to extend healthcare access to every corner of the nation, fostering mutual growth and innovation. 💊💡 #PharmaAlliance #HealthcareAccess #CollaborationWins #MNCIndiaPartnership #InnovationExchange #PharmaGrowth #IndianPharmaStrength #HealthcareRevolution #GlobalLocalPartnership #MedTechSynergy #Emcure #EmcurePharmaceuticals #Healthcare #Pharmaceuticals #LifeAtEmcure #EmcureTeam #PharmaLeadership #HealthcareInnovation

India's pharmaceutical sector continues to make waves on the global stage, securing a remarkable 16.9% share of the market for penicillin and streptomycin-based medicaments. This achievement underscores India's commitment to quality, innovation, and excellence in healthcare. Join us in celebrating this significant milestone and exploring new opportunities for growth and collaboration in the global pharmaceutical industry! Connect with Industry Experts and we can help you navigate the opportunities. https://lnkd.in/dr9BMYVv #industryexperts #business #growth #industryexpertspvtltd #indianmanufacturing #foreigntrade #PharmaTriumph #GlobalHealthLeaders #BreakingRecord #MedicationInnovation #IndianPharma #GlobalExports #MedicineTrade #HealthcareIndustry #Pharmaceuticals #IndiaExports #TradeLeadership #EconomicGrowth #PharmaExcellence #GlobalTrade #India #HealthcareInnovation #ExportSuccess #MadeInIndia #PharmaLeaders #TradeAchievements #GlobalMarket #InnovationInHealthcare